Skip to content
Company Analysis

Apollomics Inc. APLM

A comprehensive view of key metrics, scores, and financial health for Apollomics Inc.

Overview of Apollomics, Inc.

APLM NCM
Healthcare Biotechnology Framework: Biotech / Pre-Revenue Micro Cap
Apollomics, Inc. (APLM), is a Micro Cap company, in the Biotechnology industry, last closed at $19.97, about 0.0% overvalued vs fair value, +41.5% 1Y return, ranked 899/1145 in sector.
Metrics ROE -1305.4% Div Yield 0.00%
USD 19.97
0.35%
(Delayed)
• Vol 90d: 110.8%
52-Week Range
Market Cap
$43.86M
Enterprise Value
$40.58M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Good
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Weak
Profitability
Good
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 88%
Confidence: 87%
Updated: Oct 24
Top Beats
No strong beats yet

Quick Facts

Website https://www.apollomicsinc.com
HQ Foster City, CA
Employees 13
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$-1
$0
$0
Current: $19.97

Engine Room Money Flow™

Micro Cap

Biotech / Pre-Revenue - Where revenue goes and how value is created

Flow Steps
Cash on Hand
$3.3M
-66.5%%
Total Revenue
$8.5M
Net Income
-$10.9M
79.7%%
Operating Expense
$17.7M
-57.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Biotech / Pre-Revenue

Quality & Reliability Indicators

Cash Runway
3.8 months
Poor

Critical: Cash runway under 12 months

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Apollomics Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
56
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • ROIC Sustainably Above Peers ROIC at 95.5th percentile exceeds peers and WACC, demonstrating superior capital allocation.
  • Scale Supporting Profitability Profitability at scale is strong (score 0.72), demonstrating competitive advantages.

Key risks

  • Commodity Pressure / Weak Differentiation Gross margin at 0th percentile with high volatility suggests weak pricing power or commoditized products.
  • Elevated Debt Risk Debt serviceability is weak (score 0.28), raising refinancing risk.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
36
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Pre-Revenue Biotech vs Industry Peers 60% Coverage
Trade-Off Triangle Visualization A ternary plot showing APLM's balance between Growth (51.4%), Profitability (21.0%), and Safety (27.6%). Growth 51% Safety 28% Profitability 21%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

81th percentile vs peers
81
Key Signals
TSR 91.7% 81p
Strengths
  • Growth performance in top 20% of peers (percentile: 81)
  • TSR in top 20% of peers (91.7%, 81th percentile)
Risks

No significant risks identified for this axis.

Profitability

- vs peers
-
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

43th percentile vs peers
44
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Apollomics Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-0.28
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000